1 Selective Cox-2 Inhibitors Market Overview
1.1 Product Overview and Scope of Selective Cox-2 Inhibitors
1.2 Classification of Selective Cox-2 Inhibitors by Types
1.2.1 Global Selective Cox-2 Inhibitors Revenue Comparison by Types (2020-2025)
1.2.2 Global Selective Cox-2 Inhibitors Revenue Market Share by Types in 2018
1.2.3 Meloxicam
1.2.4 Celecoxib
1.2.5 Etoricoxib
1.2.6 Imrecoxib
1.2.7 Etodolac
1.2.8 Parecoxib
1.2.9 Other
1.3 Global Selective Cox-2 Inhibitors Market by Application
1.3.1 Global Selective Cox-2 Inhibitors Market Size and Market Share Comparison by Applications (2015-2025)
1.3.2 Rheumatoid Arthritis
1.3.3 Osteoarthritis
1.3.4 Spondylosis Chronica Ankylopoietica
1.3.5 Other
1.4 Global Selective Cox-2 Inhibitors Market by Regions
1.4.1 Global Selective Cox-2 Inhibitors Market Size (Million USD) Comparison by Regions (2015-2025)
1.4.1 North America (USA, Canada and Mexico) Selective Cox-2 Inhibitors Status and Prospect (2015-2025)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Selective Cox-2 Inhibitors Status and Prospect (2015-2025)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Selective Cox-2 Inhibitors Status and Prospect (2015-2025)
1.4.4 South America (Brazil, Argentina, Colombia) Selective Cox-2 Inhibitors Status and Prospect (2015-2025)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Selective Cox-2 Inhibitors Status and Prospect (2015-2025)
1.5 Global Market Size of Selective Cox-2 Inhibitors (2015-2025)
2 Manufacturers Profiles
2.1 Boehringer-Ingelheim
2.1.1 Business Overview
2.1.2 Selective Cox-2 Inhibitors Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Boehringer-Ingelheim Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.2 TerSera Therapeutics
2.2.1 Business Overview
2.2.2 Selective Cox-2 Inhibitors Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 TerSera Therapeutics Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.3 Iroko Pharmaceuticals
2.3.1 Business Overview
2.3.2 Selective Cox-2 Inhibitors Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Iroko Pharmaceuticals Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.4 Apotex
2.4.1 Business Overview
2.4.2 Selective Cox-2 Inhibitors Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Apotex Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.5 Yung Shin Pharmaceutical
2.5.1 Business Overview
2.5.2 Selective Cox-2 Inhibitors Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Yung Shin Pharmaceutical Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.6 Breckenridge Pharmaceutical
2.6.1 Business Overview
2.6.2 Selective Cox-2 Inhibitors Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Breckenridge Pharmaceutical Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.7 Meda Pharmaceuticals
2.7.1 Business Overview
2.7.2 Selective Cox-2 Inhibitors Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Meda Pharmaceuticals Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.8 Cipla
2.8.1 Business Overview
2.8.2 Selective Cox-2 Inhibitors Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Cipla Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.9 Glenmark Pharmaceuticals
2.9.1 Business Overview
2.9.2 Selective Cox-2 Inhibitors Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Glenmark Pharmaceuticals Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.10 Teva
2.10.1 Business Overview
2.10.2 Selective Cox-2 Inhibitors Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Teva Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.11 PuraCap Pharmaceutical
2.11.1 Business Overview
2.11.2 Selective Cox-2 Inhibitors Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 PuraCap Pharmaceutical Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.12 Almirall Limited
2.12.1 Business Overview
2.12.2 Selective Cox-2 Inhibitors Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Almirall Limited Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.13 Lupin Pharmaceuticals
2.13.1 Business Overview
2.13.2 Selective Cox-2 Inhibitors Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Lupin Pharmaceuticals Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.14 Aurobindo Pharma
2.14.1 Business Overview
2.14.2 Selective Cox-2 Inhibitors Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Aurobindo Pharma Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.15 Pfizer
2.15.1 Business Overview
2.15.2 Selective Cox-2 Inhibitors Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Pfizer Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.16 Mylan
2.16.1 Business Overview
2.16.2 Selective Cox-2 Inhibitors Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Mylan Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.17 Shire Pharmaceuticals
2.17.1 Business Overview
2.17.2 Selective Cox-2 Inhibitors Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Shire Pharmaceuticals Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.18 Bayer
2.18.1 Business Overview
2.18.2 Selective Cox-2 Inhibitors Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Bayer Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.19 Novacap
2.19.1 Business Overview
2.19.2 Selective Cox-2 Inhibitors Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Novacap Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.20 Abbott
2.20.1 Business Overview
2.20.2 Selective Cox-2 Inhibitors Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Abbott Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.21 Geri-Care
2.21.1 Business Overview
2.2.2 Selective Cox-2 Inhibitors Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Geri-Care Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.22 Perrigo
2.22.1 Business Overview
2.22.2 Selective Cox-2 Inhibitors Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Perrigo Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.23 Kopran
2.23.1 Business Overview
2.23.2 Selective Cox-2 Inhibitors Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Kopran Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.24 Merck
2.24.1 Business Overview
2.24.2 Selective Cox-2 Inhibitors Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Merck Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.25 Hengrui pharmaceutical
2.25.1 Business Overview
2.25.2 Selective Cox-2 Inhibitors Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Hengrui pharmaceutical Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.26 Kelun Group
2.26.1 Business Overview
2.26.2 Selective Cox-2 Inhibitors Type and Applications
2.26.2.1 Product A
2.26.2.2 Product B
2.26.3 Kelun Group Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.27 Qilu Pharmaceutical
2.27.1 Business Overview
2.27.2 Selective Cox-2 Inhibitors Type and Applications
2.27.2.1 Product A
2.27.2.2 Product B
2.27.3 Qilu Pharmaceutical Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
2.28 Taro Pharmaceuticals
2.28.1 Business Overview
2.28.2 Selective Cox-2 Inhibitors Type and Applications
2.28.2.1 Product A
2.28.2.2 Product B
2.28.3 Taro Pharmaceuticals Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2019)
3 Global Selective Cox-2 Inhibitors Market Competition, by Players
3.1 Global Selective Cox-2 Inhibitors Revenue and Share by Players (2015-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Selective Cox-2 Inhibitors Players Market Share
3.2.2 Top 10 Selective Cox-2 Inhibitors Players Market Share
3.3 Market Competition Trend
4 Global Selective Cox-2 Inhibitors Market Size by Regions
4.1 Global Selective Cox-2 Inhibitors Revenue and Market Share by Regions
4.2 North America Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
4.3 Europe Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
4.4 Asia-Pacific Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
4.5 South America Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
4.6 Middle East and Africa Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
5 North America Selective Cox-2 Inhibitors Revenue by Countries
5.1 North America Selective Cox-2 Inhibitors Revenue by Countries (2015-2019)
5.2 USA Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
5.3 Canada Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
5.4 Mexico Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
6 Europe Selective Cox-2 Inhibitors Revenue by Countries
6.1 Europe Selective Cox-2 Inhibitors Revenue by Countries (2015-2019)
6.2 Germany Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
6.3 UK Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
6.4 France Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
6.5 Russia Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
6.6 Italy Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
7 Asia-Pacific Selective Cox-2 Inhibitors Revenue by Countries
7.1 Asia-Pacific Selective Cox-2 Inhibitors Revenue by Countries (2015-2019)
7.2 China Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
7.3 Japan Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
7.4 Korea Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
7.5 India Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
7.6 Southeast Asia Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
8 South America Selective Cox-2 Inhibitors Revenue by Countries
8.1 South America Selective Cox-2 Inhibitors Revenue by Countries (2015-2019)
8.2 Brazil Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
8.3 Argentina Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
8.4 Colombia Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
9 Middle East and Africa Revenue Selective Cox-2 Inhibitors by Countries
9.1 Middle East and Africa Selective Cox-2 Inhibitors Revenue by Countries (2015-2019)
9.2 Saudi Arabia Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
9.3 UAE Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
9.4 Egypt Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
9.5 Nigeria Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
9.6 South Africa Selective Cox-2 Inhibitors Revenue and Growth Rate (2015-2019)
10 Global Selective Cox-2 Inhibitors Market Segment by Type
10.1 Global Selective Cox-2 Inhibitors Revenue and Market Share by Type (2015-2019)
10.2 Global Selective Cox-2 Inhibitors Market Forecast by Type (2020-2025)
10.3 Meloxicam Revenue Growth Rate (2015-2025)
10.4 Celecoxib Revenue Growth Rate (2015-2025)
10.5 Etoricoxib Revenue Growth Rate (2015-2025)
10.6 Imrecoxib Revenue Growth Rate (2015-2025)
10.7 Etodolac Revenue Growth Rate (2015-2025)
10.8 Parecoxib Revenue Growth Rate (2015-2025)
10.9 Other Revenue Growth Rate (2015-2025)
11 Global Selective Cox-2 Inhibitors Market Segment by Application
11.1 Global Selective Cox-2 Inhibitors Revenue Market Share by Application (2015-2019)
11.2 Selective Cox-2 Inhibitors Market Forecast by Application (2020-2025)
11.3 Rheumatoid Arthritis Revenue Growth (2015-2019)
11.4 Osteoarthritis Revenue Growth (2015-2019)
11.5 Spondylosis Chronica Ankylopoietica Revenue Growth (2015-2019)
11.6 Other Revenue Growth (2015-2019)
12 Global Selective Cox-2 Inhibitors Market Size Forecast (2020-2025)
12.1 Global Selective Cox-2 Inhibitors Market Size Forecast (2020-2025)
12.2 Global Selective Cox-2 Inhibitors Market Forecast by Regions (2020-2025)
12.3 North America Selective Cox-2 Inhibitors Revenue Market Forecast (2020-2025)
12.4 Europe Selective Cox-2 Inhibitors Revenue Market Forecast (2020-2025)
12.5 Asia-Pacific Selective Cox-2 Inhibitors Revenue Market Forecast (2020-2025)
12.6 South America Selective Cox-2 Inhibitors Revenue Market Forecast (2020-2025)
12.7 Middle East and Africa Selective Cox-2 Inhibitors Revenue Market Forecast (2020-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
